Kalpana S. Reddy, MD retweeted
Treating persons with heme malignancies in limited resources settings is extremely challenging.
Yet, this is hardly discussed in top venues or forums.
I hope you like my editorial The Underrepresented Majority now in @TheLancetHaem
thelancet.com/journals/lanha…
Kalpana S. Reddy, MD retweeted
French architect and designer Emmanuelle Moureaux's large-scale interactive installation created with thousands of coloured paper cut numerals, known as the 'Forest of Numbers' #WomensArt
Kalpana S. Reddy, MD retweeted
Pure erythroid leukemia is characterized by biallelic TP53 inactivation and abnormal p53 expression patterns in de novo and secondary cases
@Haematologica
haematologica.org/article/vi…
Kalpana S. Reddy, MD retweeted
Received a call from a community oncologist expressing dismay that his #MDS patient now had two different classifications based on #ICC and #WHO…the reality of academic brutality is that our patients and communities end up paying the price #Thismuststop #Patientscomefirst – at San Antonio, TX
Kalpana S. Reddy, MD retweeted
The CAP joins dozens of medical associations in the call to halt further Medicare cuts: capatholo.gy/3cVvoil.
Kalpana S. Reddy, MD retweeted
haematologica.org/article/vi… Link to - How I diagnose and treat #CMML @Haematologica | Comprehensive and practical approach to one of the most fascinating neoplasms | Rare diseases are not rare to those afflicted by them| #notMDS #notMPN @MayoCancerCare – at Avon, CT
Kalpana S. Reddy, MD retweeted
👉🏻Diagnosis and Management of AML in Adults: 2022 ELN Recommendations from an International Expert Panel @AML_Hub @ASTCT @ASH_hematology @TheEBMT ashpublications.org/blood/ar…
Kalpana S. Reddy, MD retweeted
Our latest perspective:
Enhancing the Trajectories of Cancer Health Disparities Research: Improving Clinical Applications of Diversity, Equity, Inclusion, and Accessibility aacrjournals.org/cancerdisco…
Kalpana S. Reddy, MD retweeted
It is not open access. Kind of unfair for an “international consensus classification…” @NicoGagelmann
Kalpana S. Reddy, MD retweeted
Drumroll please .... the International Consensus Classification of Myeloid Neoplasms and Acute Leukemia: Integrating Morphological, Clinical, and Genomic Data is now available online!!! doi.org/10.1182/blood.202201…
#hemepath #SHupdatebyte
Kalpana S. Reddy, MD retweeted
Recurrent splice site mutations affect key diffuse large B-cell lymphoma genes loom.ly/mrIfrYc
Kalpana S. Reddy, MD retweeted
Proud to see our grandiose cavalcade of #ctDNA analysis in aggressive LBCLs out in @BloodJournal colors.
doi.org/10.1182/blood.202101…
🧵 Here’s what we learned from our trial by analyzing ordinary plasma samples for their extraordinary content /n
Kalpana S. Reddy, MD retweeted
Companion meeting is recorded, will be available to SH members post meeting
Not sure why the online access costs several hundred dollars. No access to SH meeting yesterday, and not access to the hemepath platform now. @TheUSCAP #USCAP2022
Kalpana S. Reddy, MD retweeted
"Molecular Diagnostic Outcomes from 700 Cases: What Can We Learn from a Retrospective Analysis of Clinical Exome Sequencing?". New #OpenAccess article from multiple @AMPath member authors.
Full FREE text: jmdjournal.org/article/S1525…
Kalpana S. Reddy, MD retweeted
Self portrait at the dressing table, 1909 by painter Zinaida Yevgenyevna Serebriakova, born in Ukraine #WomensArt
Kalpana S. Reddy, MD retweeted
In honor of #ColorectalCancerAwarenessMonth, we're pleased to share AMP's free "Molecular in My Pocket" guide on molecular biomarkers in #colorectalcancer: ow.ly/Tlez50IamtH #molpath #oncology
